ARPLEXAM 10 mg/2,5 mg/5 mg Σλοβακία - Σλοβακικά - ŠÚKL (Štátny ústav pre kontrolu liečiv)

arplexam 10 mg/2,5 mg/5 mg

les laboratoires servier - perindopril,amlodipín a indapamid - 58 - hypotensiva

Valdoxan Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatine - depresívna porucha, major

Thymanax Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

thymanax

les laboratoires servier - agomelatine - depresívna porucha, major

Tibsovo Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastické činidlá - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.